We are live on ! Find out more
NC

Nehal Chopra Ratan Capital Management

AUM $310M
1-Year Est. Return 137%
 

Nehal Chopra is the founder of Ratan Capital Management, a concentrated investment firm whose public portfolio is followed for high-conviction equity ideas. The firm’s filings often show a focused set of positions rather than a broad index-like book. Investors track Ratan as an example of a smaller, research-driven manager with differentiated stock selection.

This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+137%
3 Year Est. Return
+616.47%
5 Year Est. Return
+765.59%
10 Year Est. Return
+8,354.57%
AUM
$350M
AUM Growth
-$193M
Cap. Flow
-$216M
Cap. Flow %
-61.83%
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
3
Reduced
1
Closed
9

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$39M
2
BHC icon
Bausch Health
BHC
+$29.6M
3
CHTR icon
Charter Communications
CHTR
+$20.6M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$44.3M
2
DISH
DISH Network Corp.
DISH
+$38M
3
BABA icon
Alibaba
BABA
+$15.7M
4
AGN
Allergan plc
AGN
+$12M
5
AER icon
AerCap
AER
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 74.08%
2 Communication Services 22.51%
3 Financials 3.4%
4 Consumer Discretionary 0%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$101M 28.98%
393,783
-48,066
-11% -$12M
BHC icon
2
Bausch Health
BHC
$2.41B
$98.5M 28.16%
688,371
+220,000
+47% +$29.6M
CHTR icon
3
Charter Communications
CHTR
$17.9B
$78.8M 22.51%
472,708
+130,069
+38% +$20.6M
ENDP
4
DELISTED
Endo International plc
ENDP
$59.3M 16.95%
821,992
+569,509
+226% +$39M
HTH icon
5
Hilltop Holdings
HTH
$2.22B
$11.9M 3.4%
596,884
– –
AER icon
6
AerCap
AER
$23B
– –
-291,885
Closed -$11.9M
BABA icon
7
Alibaba
BABA
$286B
– –
-176,400
Closed -$15.7M
HLF icon
8
CALL
Herbalife
HLF
$1.33B
– –
-1,000,000
Closed -$21.9M
HLF icon
9
Herbalife
HLF
$1.33B
– –
-414,890
Closed -$9.08M
WBA
10
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-600,000
Closed -$35.6M
ENDP
11
CALL
DELISTED
Endo International plc
ENDP
– –
-300,000
Closed -$20.5M
AGN
12
CALL
DELISTED
Allergan plc
AGN
– –
-400,000
Closed -$96.5M
DISH
13
DELISTED
DISH Network Corp.
DISH
– –
-589,028
Closed -$38M
AGN
14
DELISTED
Allergan Inc
AGN
– –
-248,500
Closed -$44.3M

Similar funds

TLA
Tanglewood Legacy Advisors Houston, Texas $310M AUM 21.56% 1-Year Est. Return
OCM
Outlook Capital Management Arlington Heights, Illinois $310M AUM
ORAM
One River Asset Management Stamford, Connecticut $310M AUM 5.17% 1-Year Est. Return
BWAM
Blue Water Asset Management Grand Rapids, Michigan $310M AUM
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
SCG
Sonata Capital Group Seattle, Washington $310M AUM 18.96% 1-Year Est. Return
GCM
GKV Capital Management Walnut Creek, California $310M AUM 51.56% 1-Year Est. Return
DI
Disciplined Investments Tulsa, Oklahoma $310M AUM 22.84% 1-Year Est. Return

Nehal Chopra's Q4 2014 Portfolio in Review

As of Q4 2014, Nehal Chopra held 14 positions worth $350M, down 36% from $543M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Nehal Chopra withdrew a net $216M in Q4 2014, closing 9 positions and reducing 1 holding. Its most notable exit was Allergan Inc, an estimated $44.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 42% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Nehal Chopra added an estimated $39M to Endo International plc.

  • Nehal Chopra added most to Endo International plc in Q4 2014, an estimated $39M increase.
  • Nehal Chopra's biggest Q4 2014 reduction was Allergan plc, cutting an estimated $12M.
  • Nehal Chopra fully exited Allergan Inc in Q4 2014, selling an estimated $44.3M.
  • Nehal Chopra's ten largest holdings make up 100% of its $350M portfolio in Q4 2014.
  • Nehal Chopra opened 0 new positions and closed 9 in Q4 2014.
  • Nehal Chopra's portfolio value fell 36% quarter-over-quarter to $350M.

Based on Ratan Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.